Dexcom received a rating and price target report from Raymond James Financial while trading on Nasdaq.
3 reports, 1 independent
Updated Aug 10
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Dexcom received a rating and price target report from Raymond James Financial while trading on Nasdaq.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Dexcom receives multiple rating upgrades and price target boosts from RBC, RJF, and TD Cowen.1 source
Dexcom received a rating and price target report from Raymond James Financial.1 source
Keep exploring
The entities involved
-
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
-
Raymond James Financial
American Investment Bank and Financial Services Firm